Esperovax signs licensing agreement with UM for new manufacturing tech for vaccines
PLYMOUTH—Esperovax, a Plymouth-based developer of oral vaccines, announced a new, exclusive licensing agreement with Innovation Partners at the University of Michigan to produce vaccines and therapeutics using a novel yeast-based …